Odelepran

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 319732

CAS#: 676501-25-0

Description: Odelepran, also known as LY2196044, is a opioid receptor antagonist under development for the treatment of alcohol dependence. Endogenous opioid-mediated reward pathways may play a role in the development and maintenance of alcohol dependence.

Chemical Structure

Odelepran

CAS# 676501-25-0

Instruction

Theoretical Analysis

MedKoo Cat#: 319732
Name: Odelepran
CAS#: 676501-25-0
Chemical Formula: C20H24FN3O3
Exact Mass: 373.18
Molecular Weight: 373.428
Elemental Analysis: C, 64.33; H, 6.48; F, 5.09; N, 11.25; O, 12.85

Price and Availability

Size	Price	Availability	Quantity
10mg	USD -2
25mg	USD -2
50mg	USD -2
100mg	USD -2
200mg	USD -2
500mg	USD -2
5g	USD -1
1g	USD -1
2g	USD -1
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: LY2196044; LY 2196044; LY-2196044; Odelepran

IUPAC/Chemical Name: 6-(2-fluoro-4-(((2-(tetrahydro-2H-pyran-4-yl)ethyl)amino)methyl)phenoxy)nicotinamide

InChi Key: QWNDOCKIKKQJNN-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H24FN3O3/c21-17-11-15(12-23-8-5-14-6-9-26-10-7-14)1-3-18(17)27-19-4-2-16(13-24-19)20(22)25/h1-4,11,13-14,23H,5-10,12H2,(H2,22,25)

SMILES Code: O=C(C1=CC=C(OC2=CC=C(CNCCC3CCOCC3)C=C2F)N=C1)N

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 373.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Wong CJ, Witcher J, Mallinckrodt C, Dean RA, Anton RF, Chen Y, Fijal BA,
Ouyang H, Dharia S, Sundseth SS, Schuh KJ, Kinon BJ. A phase 2,
placebo-controlled study of the opioid receptor antagonist LY2196044 for the
treatment of alcohol dependence. Alcohol Clin Exp Res. 2014 Feb;38(2):511-20.
doi: 10.1111/acer.12257. Epub 2013 Sep 6. PubMed PMID: 24010675.

2: Ding X, He M, Kulkarni R, Patel N, Zhang X. Investigation of clinical
pharmacokinetic variability of an opioid antagonist through physiologically based
absorption modeling. J Pharm Sci. 2013 Aug;102(8):2859-74. doi:
10.1002/jps.23629. Epub 2013 Jun 11. PubMed PMID: 23761048.

3: Hillemacher T, Heberlein A, Muschler MA, Bleich S, Frieling H. Opioid
modulators for alcohol dependence. Expert Opin Investig Drugs. 2011
Aug;20(8):1073-86. doi: 10.1517/13543784.2011.592139. Epub 2011 Jun 9. Review.
PubMed PMID: 21651459.

Your view history